MRI in Crohn's disease-current and future clinical applications

Nature Reviews Gastroenterology and Hepatology

Volumn 9, Issue 1, 2012, Pages 23-31

  Fiorino, Gionata ^a   Bonifacio, Cristiana ^a   Malesci, Alberto ^a   Balzarini, Luca ^a   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGAROBA; BARIUM; GADOLINIUM; MACROGOL; MANNITOL;

ANUS FISTULA; CAPSULE ENDOSCOPY; CLINICAL FEATURE; COLON DISEASE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE ASSOCIATION; ECHOGRAPHY; HUMAN; ILEUM DISEASE; INTERMETHOD COMPARISON; INTESTINAL FIBROSIS; INTESTINE INJURY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY;

CROHN DISEASE; GASTROENTEROLOGY; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84655167155     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2011.214     Document Type: Review

References (80)

1. Peyrin-Biroulet, L. et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut http:// dx.doi.org/10.1136/gutjnl-2011- 300049.
2. Cosnes, J. et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm. Bowel Dis. 8, 244-250 (2002). (Pubitemid 34784976)
3. Peyrin-Biroulet. L., Loftus, E. V. Jr, Colombel, J. F. & Sandborn, W. J. The natural history of adult Crohn's disease in population-based cohorts. Am. J. Gastroenterol. 105, 289-297 (2010).
4. Cosnes, J., Gower-Rousseau, C., Seksik, P. & Cortot, A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140, 1785-1794 (2011).
5. Pariente, B., Peyrin-Biroulet, L., Cohen, L., Zagdanski, A. M. & Colombel, J. F. Gastroenterology review and perspective: the role of cross-sectional imaging in evaluating bowel damage in crohn disease. AJR Am. J. Roentgenol. 197, 42-49 (2011).
6. Li, Z. et al. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in BD patients responding to infliximab. Inflamm. Bowel Dis. 16, 1299-1310 (2010).
7. Shrot, S., Konen, E., Hertz, M. & Amitai, M. M. Magnetic resonance enterography: 4 years experience in a tertiary medical center. Isr. Med. Assoc. J. 13, 172-177 (2011).
8. Sinha, R., Verma, R., Verma, S. & Rajesh, A. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls. AJR Am. J. Roentgenol. 197, 76-79 (2011).
9. Ajaj, W. et al. Small bowel hydro-MR imaging for optimized ileocecal distension in Crohn's disease: should an additional rectal enema filling be performed- J. Magn. Reson. Imaging 22, 92-100 (2005). (Pubitemid 40885134)
10. Gourtsoyiannis, N. C., Papanikolaou, N. & Karantanas, A. Magnetic resonance imaging evaluation of small intestinal Crohn's disease. Best Pract. Res. Clin. Gastroenterol. 20, 137-156 (2006). (Pubitemid 43210631)
11. Panés, J. et al. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease. Aliment. Pharmacol. Ther. 34, 125-145 (2011).
12. Horsthuis, K., Bipat, S., Bennink, R. J. & Stoker, J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 247, 64-79 (2008).
13. Bodily, K. D. et al. Crohn disease: mural attenuation and thickness at contrast-enhanced CT enterography\-correlation with endoscopic and histologic findings of inflammation. Radiology 238, 505-516 (2006). (Pubitemid 43134363)
14. Low, R. N. et al. Crohn disease with endoscopic correlation: single-shot fast spin-echo and gadolinium-enhanced fat-suppressed spoiled gradient-echo MR imaging. Radiology 222, 652-660 (2002). (Pubitemid 34215209)
15. Rimola, J. et al. Magnetic resonance for assessment of disease activity and severity in leocolonic Crohn's disease. Gut 58, 1113-1120 (2009).
16. Van Assche, G. et al. Magnetic resonance maging of the effects of infliximab on perianal fistulizing Crohn's disease. Am. J. Gastroenterol. 98, 332-339 (2003). (Pubitemid 36232382)
17. Rimola, J. et al. Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm. Bowel Dis. 17, 1759-1768 (2011).
18. Sailer, J. et al. Anastomotic recurrence of Crohn's disease after ileocolic resection: comparison of MR enteroclysis with endoscopy Eur. Radiol. 18, 2512-2521 (2008).
19. Masselli, G., Casciani, E., Polettini, E. & Gualdi, G. Comparison of MR enteroclysis with MR enterography and conventional enteroclysis in patients with Crohn's disease. Eur. Radiol. 18, 438-447 (2008). (Pubitemid 351248175)
20. Kroeker, K. I., Lam, S., Birchall, I. & Fedorak, R. N. Patients with IBD are exposed to high levels of ionizing radiation through CT scan diagnostic imaging: a five-year study. J. Clin. Gastroenterol. 45, 34-39 (2011).
21. Fuchs, Y. et al. Pediatric inflammatory bowel disease and imaging-related radiation: are we increasing the likelihood of malignancy- J. Pediatr. Gastroenterol. Nutr. 52, 280-285 (2011).
22. Forbes, A. & Reading, N. G. Review article: the risks of malignancy from either mmunosuppression or diagnostic radiation in inflammatory bowel disease. Aliment. Pharmacol. Ther. 9, 465-470 (1995).
23. Brenner, D. J. et al. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc. Natl Acad. Sci. USA 100, 13761-13766 (2003). (Pubitemid 37499140)
24. Van Assche, G. et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J. Crohns Colitis 4, 7-27 (2010).
25. Mary, J. Y. & Modigliani, R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut 30, 983-989 (1989).
26. Ordás, I. et al. Accuracy of MRI to assess therapeutic responses and mucosal healing in Crohn's disease. Gastroenterology 140, S73 (2011).
27. Pilleul, F. et al. Magnetic resonance imaging in Crohn's disease. Gastroenterol. Clin. Biol. 29, 803-808 (2005). (Pubitemid 41411360)
28. Maccioni, F. et al. MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 238, 517-530 (2006).
29. Lee, S. S. et al. Crohn disease of the smal bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 251, 751-761 (2009).
30. Florie, J. et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin. Gastroenterol. Hepatol. 3, 1221-1228 (2005). (Pubitemid 41797674)
31. Masselli, G., Vecchioli, A. & Gualdi, G. F. Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis. Abdom. Imaging 31, 400-409 (2006). (Pubitemid 46352049)
32. Gee, M. S. et al. Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am. J. Roentgenol. 197, 224-231 (2011).
33. Giusti, S. et al. Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. Abdom. Imaging 35, 646-653 (2010).
34. Zappa, M. et al. Which magnetic resonance maging findings accurately evaluate inflammation in small bowel Crohn's disease- A retrospective comparison with surgical pathologic analysis. Inflamm. Bowel Dis. 17, 984-993 (2011).
35. Aisen, A. M. Science to practice: can the diagnosis of fibrosis with magnetization contrast MR aid in the evaluation of patients with Crohn disease- Radiology 259, 1-3 (2011).
36. Adler, J. et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 259, 127-135 (2011).
37. Rutgeerts, P. et al. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 25, 665-672 (1984). (Pubitemid 14122134)
38. Koilakou, S. et al. Endoscopy and MR enteroclysis: equivalent tools in predicting clinical recurrence in patients with Crohn's disease after ileocolic resection. Inflamm. Bowel Dis. 16, 198-203 (2010).
39. Beets-Tan, R. G. et al. Preoperative MR imaging of anal fistulas: Does it really help the surgeon- Radiology 218, 75-84 (2001). (Pubitemid 32151275)
40. Van Assche, G. et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J. Crohn's Colitis 4, 63-101 (2010).
41. Karmiris, K. et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin. Gastroenterol. Hepatol. 9, 130-136 (2011).
42. Tougeron, D. et al. Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease. Dig. Dis. Sci. 54, 1746-1752 (2009).
43. Savoye-Collet, C., Savoye, G., Koning, E., Dacher, J. N. & Lerebours, E. Fistulizing perianal Crohn's disease: Contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-alpha therapy. Inflamm. Bowel Dis. 17, 1751-1758 (2011).
44. Ochsenkühn, T. et al. Crohn disease of the smal bowel proximal to the terminal ileum: detection by MR-enteroclysis. Scand. J. Gastroenterol. 39, 953-960 (2004). (Pubitemid 39388459)
45. Dillman, J. R. et al. Comparison of MR enterography and histopathology in the evaluation of pediatric Crohn disease. Pediatr. Radiol. http://dx.doi.org/10.1007/s00247-011-2186-0.
46. Albert, J. G. et al. Diagnosis of small bowel Crohn's disease: a prospective comparison of capsule endoscopy with magnetic resonance maging and fluoroscopic enteroclysis. Gut 54, 1721-1727 (2005). (Pubitemid 41697670)
47. Tillack, C. et al. Correlation of magnetic resonance enteroclysis (MRE) and wireless capsule endoscopy (CE) in the diagnosis of small bowel lesions in Crohn's disease. Inflamm. Bowel Dis. 14, 1219-1228 (2008).
48. Low, R. N., Francis, I. R., Politoske, D. & Bennett, M. Crohn's disease evaluation: comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J. Magn. Reson. Imaging 11, 127-135 (2000). (Pubitemid 30080965)
49. Siddiki, H. A. et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR Am. J. Roentgenol. 193, 113-121 (2009).
50. Neurath, M. F. et al. Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies. Am. J. Gastroenterol. 97, 1978-1985 (2002).
51. Hyun, S. B. et al. Magnetic resonance enterocolonography is useful for simultaneous evaluation of small and large intestinal lesions in Crohn's disease. Inflamm. Bowel Dis. 17, 1063-1072 (2011).
52. Jensen, M. D., Nathan, T., Rafaelsen, S. R. & Kjeldsen, J. Diagnostic accuracy of capsule endoscopy for small bowel Crohn's disease is superior to that of MR enterography or CT enterography. Clin. Gastroenterol. Hepatol. 9, 124-129 (2011).
53. Parisinos, C. A. et al. Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort study Inflamm. Bowel Dis. 16, 1219-1226 (2010).
54. Langhorst, J. et al. MR colonography without bowel purgation for the assessment of inflammatory bowel diseases: diagnostic accuracy and patient acceptance. Inflamm. Bowel Dis. 13, 1001-1008 (2007). (Pubitemid 47309972)
55. Abujudeh, H. H., Kosaraju, V. K. & Kaewlai, R. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections. AJR Am. J. Roentgenol. 194, 430-434 (2010).
56. Kribben, A. et al. Nephrogenic systemic fibrosis: pathogenesis, diagnosis, and therapy. J. Am. Coll. Cardiol. 53, 1621-1628 (2009).
57. Collidge, T. A. et al. Gadolinium-enhanced MR maging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort. Radiology 245, 168-175 (2007). (Pubitemid 47417800)
58. Kanal, E. et al. ACR guidance document for safe MR practices: 2007. AJR Am. J. Roentgenol. 188, 1447-1474 (2007). (Pubitemid 46866845)
59. Chen, M. M., Coakley, F. V., Kaimal, A. & Laros, R. K. Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet. Gynecol. 112, 333-340 (2008).
60. Chang, K. J., Kamel, I. R., Macura, K. J. & Bluemke, D. A. 3.0-T MR imaging of the abdomen: comparison with 1.5 T. Radiographics 28, 1983-1998 (2008).
61. Rimola, J. et al. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics 29, 701-709 (2009).
62. Fiorino, G. et al. A prospective comparison between 1.5T magnetic resonance and 3T magnetic resonance in ileo-colonic Crohn's disease: a single center experience. Gastroenterology 140, S-695 (2011).
63. Dagia, C., Ditchfield, M., Kean, M. & Catto-Smith, T. Imaging for Crohn disease: use of 3-T MRI in a paediatric setting. J. Med. Imaging Radiat Oncol. 52, 480-488 (2008).
64. Oussalah, A. et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 59, 1056-1065 (2010).
65. Oto, A. et al. Evaluation of diffusion-weighted MR maging for detection of bowel inflammation in patients with Crohn's disease. Acad. Radiol. 16, 597-603 (2009).
66. Best, W. R., Becktel, J. M., Singleton, J. W. & Kern, F. Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 70, 439-444 (1976).
67. Harvey, R. F. & Bradshaw, J. M. A simple index of Crohn's-disease activity. Lancet 1, 1134-1135 (1980).
68. Daperno, M. et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest. Endosc. 60, 505-512 (2004). (Pubitemid 39311530)
69. Lewis, J. D. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology. 140, 1817-1826 (2011).
70. Van Assche, G. et al. Effects of infliximab therapy on transmural lesions assessed by MR enteroclysis in patients with ileal Crohn's disease: The ACTIF Study. Gastroenterology 140, S-73 (2011).
71. Sharp, J. T., Lidsky, M. D., Collins, L. C. & Moreland, J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis. Correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum. 14, 706-720 (1971).
72. van der Heijde, D. M. Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin. Rheumatol. 10, 435-453 (1996).
73. van der Heijde, D. M. Joint erosions and patients with early rheumatoid arthritis. Br. J. Rheumatol. 34, 74-78 (1995).
74. St Clair, E. W. et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 50, 3432-3443 (2004). (Pubitemid 39488667)
75. Bejarano, V et al. The relationship between early bone mineral density changes and long term function and radiographic progression in rheumatoid arthritis. Arthritis Care Res. (Hoboken) http://dx.doi.org/ 10.1002/ acr.20553.
76. Pariente, B. et al. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm. Bowel Dis. 17, 1415-1422 (2011).
77. Peyrin-Biroulet, L., Loftus, E. V Jr, Colombel, J. F. & Sandborn, W. J. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut 59, 141-147 (2010).
78. D'Haens, G. et al. Early combined mmunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial. Lancet 371, 660-667 (2008). (Pubitemid 351284485)
79. Taylor, S. A. et al. Mural Crohn disease: correlation of dynamic contrast-enhanced MR maging findings with angiogenesis and inflammation at histologic examination\-pilot study. Radiology 251, 369-379 (2009).
80. Horsthuis, K., Lavini, C., Bipat, S., Stokkers, P C. & Stoker, J. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251, 380-387 (2009).